2514-30-9,MFCD05856231
Catalog No.:AA00BJGQ

2514-30-9 | 2-(4-Methylphenyl)-1,2-benzisothiazol-3(2h)-one

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$53.00   $37.00
- +
5mg
≥98%
in stock  
$129.00   $90.00
- +
10mg
≥98%
in stock  
$230.00   $161.00
- +
100mg
95%
in stock  
$335.00   $234.00
- +
250mg
95%
in stock  
$616.00   $431.00
- +
1g
95%
in stock  
$1,463.00   $1,024.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00BJGQ
Chemical Name:
2-(4-Methylphenyl)-1,2-benzisothiazol-3(2h)-one
CAS Number:
2514-30-9
Molecular Formula:
C14H11NOS
Molecular Weight:
241.3082
MDL Number:
MFCD05856231
SMILES:
Cc1ccc(cc1)n1sc2c(c1=O)cccc2
Properties
Computed Properties
 
Complexity:
299  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.4  

Literature

Title: Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.

Journal: The Journal of biological chemistry 20130329

Title: Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia.

Journal: Journal of medicinal chemistry 20110526

Title: Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening.

Journal: ChemMedChem 20101203

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:2514-30-9 Molecular Formula|2514-30-9 MDL|2514-30-9 SMILES|2514-30-9 2-(4-Methylphenyl)-1,2-benzisothiazol-3(2h)-one
Catalog No.: AA00BJGQ
2514-30-9,MFCD05856231
2514-30-9 | 2-(4-Methylphenyl)-1,2-benzisothiazol-3(2h)-one
Pack Size: 1mg
Purity: ≥98%
in stock
$53.00 $37.00
Pack Size: 5mg
Purity: ≥98%
in stock
$129.00 $90.00
Pack Size: 10mg
Purity: ≥98%
in stock
$230.00 $161.00
Pack Size: 100mg
Purity: 95%
in stock
$335.00 $234.00
Pack Size: 250mg
Purity: 95%
in stock
$616.00 $431.00
Pack Size: 1g
Purity: 95%
in stock
$1,463.00 $1,024.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00BJGQ
Chemical Name: 2-(4-Methylphenyl)-1,2-benzisothiazol-3(2h)-one
CAS Number: 2514-30-9
Molecular Formula: C14H11NOS
Molecular Weight: 241.3082
MDL Number: MFCD05856231
SMILES: Cc1ccc(cc1)n1sc2c(c1=O)cccc2
Properties
Complexity: 299  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 17  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.4  
Literature fold

Title: Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.

Journal: The Journal of biological chemistry20130329

Title: Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia.

Journal: Journal of medicinal chemistry20110526

Title: Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening.

Journal: ChemMedChem20101203

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Building Blocks More >
228418-85-7
228418-85-7
(R)-(-)-LY 426965 dihydrochloride
AA00BJUW | MFCD24387525
263153-46-4
263153-46-4
Benzaldehyde, 2-hydroxy-, hydrazone, [C(E)]- (9CI)
AA00BKZM | MFCD00007626
26774-38-9
26774-38-9
3-Chloro-n-1,3-thiazol-2-ylpropanamide
AA00BNAN | MFCD02766994
20344-79-0
20344-79-0
2,3-Diaminofumaronitrile
AA00BP5Y | MFCD00064109
21409-25-6
21409-25-6
2-(Benzhydryloxy)acetic acid
AA00BRJC | MFCD00772537
306-11-6
306-11-6
[2-hydroxy-3-(m-tolyloxy)propyl]isopropylammonium chloride
AA00BUEE | MFCD01696861
30126-05-7
30126-05-7
THIENO[3,2-B][1]BENZOTHIOPHENE-2-CARBOXYLIC ACID
AA00BWFQ | MFCD01927335
37074-39-8
37074-39-8
1-(4-Chloro-3-methylphenyl)ethanone
AA00BXAG | MFCD00045172
42482-94-0
42482-94-0
ETHYL 5-(4-METHYLPHENYL)-5-OXOVALERATE
AA00BXH3 | MFCD01320218
4072-67-7
4072-67-7
4,4'-Bis(2-bromoacetyl)biphenyl
AA00BXNN | MFCD00017877
Submit
© 2017 AA BLOCKS, INC. All rights reserved.